ARCHIVES

ASCO, AACR Call NCI Bypass Budget A Key Advocacy Tool, Seek Larger Role In Writing It.

This article is from The Cancer Letter archive.

Vol. 26 No. 28 | July 14, 2000

Download PDF Visit The Full Archive

Related Articles

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

February 6, 2004

Xeloda + Oxaliplatin Compares To FOLFOX-4 In First Line

January 30, 2009

Bush Names Leffall Cancer Panel Chairman, Appoints Cyclist Armstrong To Panel

May 31, 2002

Freireich Blasts Prevention Advocates, Defends Treatment

September 15, 1978

Holland, Leader Win $250,00 Milken Awards: Six Others Get $50,000 Prizes

December 9, 1988

EntreMed Begins Phase I/II Trial For Endostatin.

July 27, 2001